Stefan Nygaard Hansen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Stefan Nygaard Hansen has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Bodil Hammer Bech
Department of Public Health Aarhus University Aarhus Denmark
8 shared publications - Charlotte Ulrikka Rask
Department of Child and Adolescent Psychiatry Aarhus University Hospital Psychiatry Aarhus Denmark
5 shared publications - Dorte Rytter
Department of Public Health, Aarhus University, Aarhus, Denmark
5 shared publications - Sanne Marie Thysen
Department of Clinical Pharmacology University Hospital Copenhagen, Bispebjerg and Frederiksberg Copenhagen Denmark
5 shared publications - Thomas Meinertz Dantoft
Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
5 shared publications - Christina Bisgaard Jensen
Department of Public Health, Aarhus University, Aarhus, 8000, Denmark
4 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Elsevier in Public Health
- Vol. 259, 106429
Acute symptoms and subsequent post-acute symptoms following COVID-19 vaccination: A Danish population-based study
- 28 July 2026
- Published by Elsevier in Public Health
- Vol. 259, 106429
Open AccessAcute symptoms and subsequent post-acute symptoms following COVID-19 vaccination: A Danish population-based study
- Open Access
- 12 June 2026
- Published by Taylor & Francis in Infectious Diseases
- Vol. 58 (10) , 1-13
Fatigue, neurological, and cognitive symptoms after COVID-19 - a nationwide matched cohort study in Denmark
To investigate if COVID-19 increases the odds of fatigue, headache, dizziness, concentration difficulties, and memory impairment as well as at least three of these symptoms, at 12 weeks after COVID-19. Additionally, we investigated whether symptoms were influenced by severity of COVID-19, sex, and pre-infection COVID-19 vaccination. This study utilised data from the DanishBiCoVac cohort and national registers. The BiCoVac cohort collected information about symptoms through four questionaries distributed between May 2021 and May 2022. Participants with COVID-19 were matched to participants without COVID-19.Three matching samples were created according to time since COVID-19. Logistic regression was performed for the association between COVID-19 and each outcome. Participants with COVID-19 within 0-4 weeks had higher odds of reporting all outcomes compared to participants without COVID-19. Between 4 and 12 weeks after COVID-19, the odds of symptoms were also higher, although attenuated. After 12 weeks, participants with COVID-19 also had higher odds of symptoms except for concentration difficulties compared to those without COVID-19. Odds for symptoms were highest for participants reporting severe infection. Prior COVID-19 vaccination might weaken the association while no clear modification was found for sex. Participants with COVID-19 had higher odds of all outcomes, especially within the first 4 weeks. After 12 weeks, the ORs were attenuated but still indicated an association for all outcomes except concentration difficulties. Individuals vaccinated against COVID-19 tended to report fewer symptoms after COVID-19. Participants with severe COVID-19 had the highest odds of symptoms.
- 12 June 2026
- Published by Taylor & Francis in Infectious Diseases
- Vol. 58 (10) , 1-13
Open AccessFatigue, neurological, and cognitive symptoms after COVID-19 - a nationwide matched cohort study in Denmark
To investigate if COVID-19 increases the odds of fatigue, headache, dizziness, concentration difficulties, and memory impairment as well as at least three of these symptoms, at 12 weeks after COVID-19. Additionally, we investigated whether symptoms were influenced by severity of COVID-19, sex, and pre-infection COVID-19 vaccination. This study utilised data from the DanishBiCoVac cohort and national registers. The BiCoVac cohort collected information about symptoms through four questionaries distributed between May 2021 and May 2022. Participants with COVID-19 were matched to participants without COVID-19.Three matching samples were created according to time since COVID-19. Logistic regression was performed for the association between COVID-19 and each outcome. Participants with COVID-19 within 0-4 weeks had higher odds of reporting all outcomes compared to participants without COVID-19. Between 4 and 12 weeks after COVID-19, the odds of symptoms were also higher, although attenuated. After 12 weeks, participants with COVID-19 also had higher odds of symptoms except for concentration difficulties compared to those without COVID-19. Odds for symptoms were highest for participants reporting severe infection. Prior COVID-19 vaccination might weaken the association while no clear modification was found for sex. Participants with COVID-19 had higher odds of all outcomes, especially within the first 4 weeks. After 12 weeks, the ORs were attenuated but still indicated an association for all outcomes except concentration difficulties. Individuals vaccinated against COVID-19 tended to report fewer symptoms after COVID-19. Participants with severe COVID-19 had the highest odds of symptoms.
- 18 August 2025
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 54 (5)
Post-acute non-specific symptoms following COVID-19 vaccination: a Danish population-based study
Background: Post-acute non-specific symptoms such as headaches, muscular pain, and fatigue are frequently reported following COVID-19 vaccination, raising concerns about adverse events. As vaccine-hesitant individuals may be more likely to experience symptoms of vaccines, this study investigates whether COVID-19 vaccination increases the odds of post-acute non-specific symptoms, stratified by COVID-19 vaccine hesitancy. Methods: This longitudinal study uses repeated measurements from the BiCoVac cohort—a random sample of 913 116 Danish citizens aged 16–65 years. Data were collected through national registers and questionnaires (May 2021–June 2022). Non-specific symptoms were identified by using the 25-item Bodily Distress Syndrome checklist and analysed by using logistic and linear regression models comparing vaccinated and unvaccinated individuals. Models were fitted with robust standard errors and inverse probability of selection weights. Results: A total of 132 776 observations were collected from 61 316 COVID-19 vaccine-unconcerned individuals, 52 325 observations from 25 272 COVID-19 vaccine-sceptical individuals, and 10 242 observations from 5064 COVID-19 vaccine-concerned individuals. Among the vaccine-unconcerned individuals, those vaccinated had lower odds of most symptoms compared with unvaccinated individuals >4 weeks post-vaccination [e.g. muscular pain: odds ratio (OR) = 0.56, 95% confidence interval (CI): 0.47–0.68]. A similar tendency was found for vaccine-sceptical individuals, although with attenuated estimates. Conversely, among vaccine-concerned individuals, we observed a tendency for higher odds of most symptoms >4 weeks post-vaccination compared with unvaccinated individuals (e.g. muscular pain: OR = 1.23, 95% CI: 0.91–1.67). Conclusion: For most individuals aged 16–65 years, we found no evidence of post-acute symptoms after COVID-19 vaccination. Vaccinated vaccine-concerned individuals were, however, more likely to report most symptoms, potentially due to reporting bias or nocebo effects.
- 18 August 2025
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 54 (5)
Post-acute non-specific symptoms following COVID-19 vaccination: a Danish population-based study
Background: Post-acute non-specific symptoms such as headaches, muscular pain, and fatigue are frequently reported following COVID-19 vaccination, raising concerns about adverse events. As vaccine-hesitant individuals may be more likely to experience symptoms of vaccines, this study investigates whether COVID-19 vaccination increases the odds of post-acute non-specific symptoms, stratified by COVID-19 vaccine hesitancy. Methods: This longitudinal study uses repeated measurements from the BiCoVac cohort—a random sample of 913 116 Danish citizens aged 16–65 years. Data were collected through national registers and questionnaires (May 2021–June 2022). Non-specific symptoms were identified by using the 25-item Bodily Distress Syndrome checklist and analysed by using logistic and linear regression models comparing vaccinated and unvaccinated individuals. Models were fitted with robust standard errors and inverse probability of selection weights. Results: A total of 132 776 observations were collected from 61 316 COVID-19 vaccine-unconcerned individuals, 52 325 observations from 25 272 COVID-19 vaccine-sceptical individuals, and 10 242 observations from 5064 COVID-19 vaccine-concerned individuals. Among the vaccine-unconcerned individuals, those vaccinated had lower odds of most symptoms compared with unvaccinated individuals >4 weeks post-vaccination [e.g. muscular pain: odds ratio (OR) = 0.56, 95% confidence interval (CI): 0.47–0.68]. A similar tendency was found for vaccine-sceptical individuals, although with attenuated estimates. Conversely, among vaccine-concerned individuals, we observed a tendency for higher odds of most symptoms >4 weeks post-vaccination compared with unvaccinated individuals (e.g. muscular pain: OR = 1.23, 95% CI: 0.91–1.67). Conclusion: For most individuals aged 16–65 years, we found no evidence of post-acute symptoms after COVID-19 vaccination. Vaccinated vaccine-concerned individuals were, however, more likely to report most symptoms, potentially due to reporting bias or nocebo effects.
- 15 April 2025
- Published by The Journal of Rheumatology in The Journal of Rheumatology
School Absence Among Children With Juvenile Idiopathic Arthritis: A National Matched Comparison Study
Objective: This study compares rates of school absence (SA) for all children with juvenile idiopathic arthritis (JIA) attending public Danish schools to peers both before and after JIA diagnosis. Further, we aimed to investigate the role of socioeconomic status (SES) on the possible association.Methods: We performed a register-based matched cohort study. We included all children attending public Danish schools between 2010 and 2019 diagnosed with JIA, and compared them to their schoolmates. Rates of differentiated and total SA both before and after JIA diagnosis were compared. In the primary study we included children diagnosed with JIA after starting school, whereas the secondary study included only children diagnosed before starting school.Results: We included 786 children with JIA and 3908 matched controls in the primary study and 382 children with JIA and 1910 matched controls in the secondary. Our primary study showed higher rates of sickness SA and total SA from 3 years before diagnosis and the following 5 years after diagnosis among children with JIA. After diagnosis, children with JIA also had significantly more legal (planned) SA. In the secondary study, we found that children diagnosed with JIA before starting school had significantly more SA (both sickness SA and legal school SA) up to grade 8. In both studies, children from low SES backgrounds, both with and without JIA, had the highest rates of SA, although no difference in the association between JIA and SA across SES groups was found.Conclusion: Children with JIA had more sickness and legal absence from school.
- 15 April 2025
- Published by The Journal of Rheumatology in The Journal of Rheumatology
School Absence Among Children With Juvenile Idiopathic Arthritis: A National Matched Comparison Study
Objective: This study compares rates of school absence (SA) for all children with juvenile idiopathic arthritis (JIA) attending public Danish schools to peers both before and after JIA diagnosis. Further, we aimed to investigate the role of socioeconomic status (SES) on the possible association.Methods: We performed a register-based matched cohort study. We included all children attending public Danish schools between 2010 and 2019 diagnosed with JIA, and compared them to their schoolmates. Rates of differentiated and total SA both before and after JIA diagnosis were compared. In the primary study we included children diagnosed with JIA after starting school, whereas the secondary study included only children diagnosed before starting school.Results: We included 786 children with JIA and 3908 matched controls in the primary study and 382 children with JIA and 1910 matched controls in the secondary. Our primary study showed higher rates of sickness SA and total SA from 3 years before diagnosis and the following 5 years after diagnosis among children with JIA. After diagnosis, children with JIA also had significantly more legal (planned) SA. In the secondary study, we found that children diagnosed with JIA before starting school had significantly more SA (both sickness SA and legal school SA) up to grade 8. In both studies, children from low SES backgrounds, both with and without JIA, had the highest rates of SA, although no difference in the association between JIA and SA across SES groups was found.Conclusion: Children with JIA had more sickness and legal absence from school.
- Open Access
- 7 February 2025
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 40 (2) , 225-233
Cohort profile: The BiCoVac cohort - a nationwide Danish cohort to assess short and long-term symptoms following COVID-19 vaccination
BiCoVac is a population-based Danish cohort aiming to examine whether Coronavirus disease 2019 (COVID-19) vaccines are associated with non-specific symptoms beyond the specific protection of COVID-19. Data were collected by four questionnaire surveys between May 2021 and July 2022 and the questionnaire distribution was aligned with the Danish COVID-19 vaccination program. All surveys collected self-reported information on symptoms (e.g., headache, nausea, and fatigue). The baseline survey additionally gathered information on lifestyle and health. Survey data were combined with data from the Danish registers including information on COVID-19 vaccination and COVID-19 test results. A total of 911,613 (25% of all Danish citizens aged 16 to 65) were randomly sampled for the cohort and 252,401 initiated the baseline questionnaire. Of these, 59% (n = 149,070) participated in the 1st follow-up, 43% (n = 107,655) in the 2nd follow-up, and 25% (n = 63,737) in the 3rd follow-up. Women and individuals above 40 years of age were more likely to participate. Among vaccinated respondents, 25–38% reported moderate to severe immediate symptoms following COVID-19 vaccination, varying by vaccine doses. Females, younger individuals, and those with prior COVID-19 reported more immediate symptoms. Results of potential non-specific symptoms following COVID-19 vaccination did not reveal higher risk of involuntary movements among vaccinated individuals compared to unvaccinated individuals. Currently (December 2024), we are further investigating the effects of COVID-19 vaccines on other non-specific symptoms and exploring whether specific characteristics render some individuals more susceptible to report non-specific symptoms. In addition, long-term symptoms following COVID-19 are being investigated.
- 7 February 2025
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 40 (2) , 225-233
Open AccessCohort profile: The BiCoVac cohort - a nationwide Danish cohort to assess short and long-term symptoms following COVID-19 vaccination
BiCoVac is a population-based Danish cohort aiming to examine whether Coronavirus disease 2019 (COVID-19) vaccines are associated with non-specific symptoms beyond the specific protection of COVID-19. Data were collected by four questionnaire surveys between May 2021 and July 2022 and the questionnaire distribution was aligned with the Danish COVID-19 vaccination program. All surveys collected self-reported information on symptoms (e.g., headache, nausea, and fatigue). The baseline survey additionally gathered information on lifestyle and health. Survey data were combined with data from the Danish registers including information on COVID-19 vaccination and COVID-19 test results. A total of 911,613 (25% of all Danish citizens aged 16 to 65) were randomly sampled for the cohort and 252,401 initiated the baseline questionnaire. Of these, 59% (n = 149,070) participated in the 1st follow-up, 43% (n = 107,655) in the 2nd follow-up, and 25% (n = 63,737) in the 3rd follow-up. Women and individuals above 40 years of age were more likely to participate. Among vaccinated respondents, 25–38% reported moderate to severe immediate symptoms following COVID-19 vaccination, varying by vaccine doses. Females, younger individuals, and those with prior COVID-19 reported more immediate symptoms. Results of potential non-specific symptoms following COVID-19 vaccination did not reveal higher risk of involuntary movements among vaccinated individuals compared to unvaccinated individuals. Currently (December 2024), we are further investigating the effects of COVID-19 vaccines on other non-specific symptoms and exploring whether specific characteristics render some individuals more susceptible to report non-specific symptoms. In addition, long-term symptoms following COVID-19 are being investigated.
- Open Access
- 31 October 2024
- Published by Elsevier in Public Health
- Vol. 237, 299-306
Does health anxiety and vaccine concern predict self-reported adverse events following COVID-19 vaccination?–A Danish national cohort study
- 31 October 2024
- Published by Elsevier in Public Health
- Vol. 237, 299-306
Open AccessDoes health anxiety and vaccine concern predict self-reported adverse events following COVID-19 vaccination?–A Danish national cohort study
- Open Access
Female Infertility and Neurodevelopmental Disorders in Children: associations and evidence for familial confounding in Denmark
IMPORTANCE: Existing research suggests the impact of infertility on the risk of neurodevelopmental disorders in children, however, studies to date have failed to separate the impact of male and female infertility, often blurring the lines with proxies that encompass all forms of infertility. Moreover, while both health conditions co-occurring with infertility and genetic factors operating upstream have been suggested to influence the association between infertility and child outcomes, their roles and potential impact on observed associations remain unclear. OBJECTIVE: The objectives of this study are to investigate the relationship between female infertility and autism in the child, differentiating it from the effects of male and the couple infertility; consider the role of various maternal and birth factors in the association; and examine the effects of shared familial confounders on the association. DESIGN SETTING AND PARTICIPANTS: Danish population-based cohort study, including all singleton live births in Denmark 1998-2015, their parents and parents’ siblings. The cohort was followed up until December 31, 2016. EXPOSURES: The exposure was a history of female infertility in the mother and the mother’s sister. We examined four definitions of female infertility based on the ICD-10 codes derived from the Danish National Patient Register - any female infertility; specified female infertility; female exclusive infertility; and female or male infertility. MAIN OUTCOME AND MEASURES: The outcome was diagnosis of autism spectrum disorder (ASD) in the Danish Psychiatric Central Research Register or the national patient register. A multivariable Cox regression model was used to estimate the associations between female infertility and autism, accounting for child’s sex, year of birth, maternal age, education level, chronic comorbidities, and pregnancy and birth complications. The effects of shared familial factors on the association were analyzed using exposure information from the child’s maternal aunt. RESULTS: The cohort included 1,131,899 mother-child pairs, among which 18,374 children with ASD diagnosis. History of female infertility in the mother (all definitions) was significantly associated with autism in the child, with the association remaining robust after adjustment for covariates (HR adj =1.14 (95% CI, 1.03-1.26) for specified infertility). The diagnosis of infertility in a child’s maternal aunt was also significantly linked to the child’s autism risk, even after adjustment for maternal infertility (HR adj =1.10 (95% CI, 1.00-1.20). CONCLUSIONS AND RELEVANCE: in This population-based birth cohort study, we found a slightly higher risk of autism in children born to mothers with a history of infertility, with the association remaining consistent across various definitions of female infertility and robust to adjustments for demographic, child, and maternal factors. The study suggests for the first time that shared familial factors, possibly both genetic and non-genetic, could be influencing both female infertility and the risk of autism in children, indicating a need for further investigation into these familial effects.
Open AccessFemale Infertility and Neurodevelopmental Disorders in Children: associations and evidence for familial confounding in Denmark
IMPORTANCE: Existing research suggests the impact of infertility on the risk of neurodevelopmental disorders in children, however, studies to date have failed to separate the impact of male and female infertility, often blurring the lines with proxies that encompass all forms of infertility. Moreover, while both health conditions co-occurring with infertility and genetic factors operating upstream have been suggested to influence the association between infertility and child outcomes, their roles and potential impact on observed associations remain unclear. OBJECTIVE: The objectives of this study are to investigate the relationship between female infertility and autism in the child, differentiating it from the effects of male and the couple infertility; consider the role of various maternal and birth factors in the association; and examine the effects of shared familial confounders on the association. DESIGN SETTING AND PARTICIPANTS: Danish population-based cohort study, including all singleton live births in Denmark 1998-2015, their parents and parents’ siblings. The cohort was followed up until December 31, 2016. EXPOSURES: The exposure was a history of female infertility in the mother and the mother’s sister. We examined four definitions of female infertility based on the ICD-10 codes derived from the Danish National Patient Register - any female infertility; specified female infertility; female exclusive infertility; and female or male infertility. MAIN OUTCOME AND MEASURES: The outcome was diagnosis of autism spectrum disorder (ASD) in the Danish Psychiatric Central Research Register or the national patient register. A multivariable Cox regression model was used to estimate the associations between female infertility and autism, accounting for child’s sex, year of birth, maternal age, education level, chronic comorbidities, and pregnancy and birth complications. The effects of shared familial factors on the association were analyzed using exposure information from the child’s maternal aunt. RESULTS: The cohort included 1,131,899 mother-child pairs, among which 18,374 children with ASD diagnosis. History of female infertility in the mother (all definitions) was significantly associated with autism in the child, with the association remaining robust after adjustment for covariates (HR adj =1.14 (95% CI, 1.03-1.26) for specified infertility). The diagnosis of infertility in a child’s maternal aunt was also significantly linked to the child’s autism risk, even after adjustment for maternal infertility (HR adj =1.10 (95% CI, 1.00-1.20). CONCLUSIONS AND RELEVANCE: in This population-based birth cohort study, we found a slightly higher risk of autism in children born to mothers with a history of infertility, with the association remaining consistent across various definitions of female infertility and robust to adjustments for demographic, child, and maternal factors. The study suggests for the first time that shared familial factors, possibly both genetic and non-genetic, could be influencing both female infertility and the risk of autism in children, indicating a need for further investigation into these familial effects.
- Open Access
- 6 April 2024
- Published by Springer Nature in Metrika
- Vol. 88 (4) , 419-443
Variance estimation for average treatment effects estimated by g-computation
The average treatment effect is used to evaluate effects of interventions in a population. Under certain causal assumptions, such an effect may be estimated from observational data using the g-computation technique. The asymptotic properties of this estimator appears not to be well-known and hence bootstrapping has become the preferred method for estimating its variance. Bootstrapping is, however, not an optimal choice for multiple reasons; it is a slow procedure and, if based on too few bootstrap samples, results in a highly variable estimator of the variance. In this paper, we consider estimators of potential outcome means and average treatment effects using g-computation. We consider these parameters for the entire population but also in subgroups, for example, the average treatment effect among the treated. We derive their asymptotic distributions in a general framework. An estimator of the asymptotic variance is proposed and shown to be consistent when g-computation is used in conjunction with the M-estimation technique. The proposed estimator is shown to be superior to the bootstrap technique in a simulation study. Robustness against model misspecification is also demonstrated by means of simulations.
- 6 April 2024
- Published by Springer Nature in Metrika
- Vol. 88 (4) , 419-443
Open AccessVariance estimation for average treatment effects estimated by g-computation
The average treatment effect is used to evaluate effects of interventions in a population. Under certain causal assumptions, such an effect may be estimated from observational data using the g-computation technique. The asymptotic properties of this estimator appears not to be well-known and hence bootstrapping has become the preferred method for estimating its variance. Bootstrapping is, however, not an optimal choice for multiple reasons; it is a slow procedure and, if based on too few bootstrap samples, results in a highly variable estimator of the variance. In this paper, we consider estimators of potential outcome means and average treatment effects using g-computation. We consider these parameters for the entire population but also in subgroups, for example, the average treatment effect among the treated. We derive their asymptotic distributions in a general framework. An estimator of the asymptotic variance is proposed and shown to be consistent when g-computation is used in conjunction with the M-estimation technique. The proposed estimator is shown to be superior to the bootstrap technique in a simulation study. Robustness against model misspecification is also demonstrated by means of simulations.
- Open Access
- 1 April 2024
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 51 (8) , 804-810
School Well-Being and Academic Performance of Children With Juvenile Idiopathic Arthritis: A National Register-Based Study
Objective: We aimed to investigate how school well-being (SWB) and academic performance of children with juvenile idiopathic arthritis (JIA) compare to their peers on a national level using the Danish national registers. Further, we investigated the potential influence of socioeconomic status (SES).Methods: A population-wide, register-based, cross-sectional study was performed. We compared the results of children with and without JIA in the Danish National Well-Being Questionnaire (DNWQ), the National Danish School Testing (NDST), and their ninth grade (aged approximately 16 yrs) final school marks in Danish and mathematics. The results were analyzed using adjusted ordinal logistic regression (SWB) and linear regression (tests and marks).Results: In separate cohorts, we included a total of 505,340 children answering the DNWQ, 812,461 children with NDST results, and the ninth-grade final marks of 581,804 children. Of these children, 1042, 1541, and 1410, respectively, fulfilled the criteria of JIA. Children with JIA reported SWB comparable to their peers, except for the question “Do you perform well in school?” (odds ratio 0.89, 95% CI 0.81-0.99). In the NDST, the children with JIA in general did just as well as their peers. We found no differences in the ninth-grade final marks in either Danish or mathematics. Stratifying the analyses on SES showed no significant differences in the associations.Conclusion: Overall, children with JIA report SWB comparable to that of children without JIA and perform equally well in school as children without JIA.
- 1 April 2024
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 51 (8) , 804-810
Open AccessSchool Well-Being and Academic Performance of Children With Juvenile Idiopathic Arthritis: A National Register-Based Study
Objective: We aimed to investigate how school well-being (SWB) and academic performance of children with juvenile idiopathic arthritis (JIA) compare to their peers on a national level using the Danish national registers. Further, we investigated the potential influence of socioeconomic status (SES).Methods: A population-wide, register-based, cross-sectional study was performed. We compared the results of children with and without JIA in the Danish National Well-Being Questionnaire (DNWQ), the National Danish School Testing (NDST), and their ninth grade (aged approximately 16 yrs) final school marks in Danish and mathematics. The results were analyzed using adjusted ordinal logistic regression (SWB) and linear regression (tests and marks).Results: In separate cohorts, we included a total of 505,340 children answering the DNWQ, 812,461 children with NDST results, and the ninth-grade final marks of 581,804 children. Of these children, 1042, 1541, and 1410, respectively, fulfilled the criteria of JIA. Children with JIA reported SWB comparable to their peers, except for the question “Do you perform well in school?” (odds ratio 0.89, 95% CI 0.81-0.99). In the NDST, the children with JIA in general did just as well as their peers. We found no differences in the ninth-grade final marks in either Danish or mathematics. Stratifying the analyses on SES showed no significant differences in the associations.Conclusion: Overall, children with JIA report SWB comparable to that of children without JIA and perform equally well in school as children without JIA.
- Open Access
Maternal Pre-Pregnancy BMI, Offspring Adiposity in Late Childhood, and Age of Weaning: A Causal Mediation Analysis
Infant feeding practices have been hypothesized to influence offspring’s body mass index (BMI) later in life, and women with overweight or obesity tend to wean their infants earlier than women with healthy BMI. We, therefore, aimed to investigate how much early age of weaning mediated the maternal-offspring adiposity relationship. The study included 4920 mother-child pairs from the Avon Longitudinal Study of Parents and Children birth cohort. G-computation was applied to estimate the natural direct (NDE) and indirect (NIE) effects, via the age of weaning (3 months), of maternal pre-pregnancy overweight or obesity on offspring’s BMI and fat mass index. The NDE of maternal overweight or obesity on offspring BMI at 17 years old was 2.63 kg/m2 (95% CI: 2.27 to 2.99). The NIE via the age of weaning was 0.02 kg/m2 (95% CI: 0.00 to 0.04), corresponding to 0.8% of the total effect. Similar results were observed for the offspring’s fat mass index. The NDE and NIE were similar to the main analyses when we looked at the relationship stratified by breastfeeding status. Our study found a minimal influence of age of weaning on the pathway between maternal and offspring adiposity, indicating the age of weaning may not be a key mediator.
Open AccessMaternal Pre-Pregnancy BMI, Offspring Adiposity in Late Childhood, and Age of Weaning: A Causal Mediation Analysis
Infant feeding practices have been hypothesized to influence offspring’s body mass index (BMI) later in life, and women with overweight or obesity tend to wean their infants earlier than women with healthy BMI. We, therefore, aimed to investigate how much early age of weaning mediated the maternal-offspring adiposity relationship. The study included 4920 mother-child pairs from the Avon Longitudinal Study of Parents and Children birth cohort. G-computation was applied to estimate the natural direct (NDE) and indirect (NIE) effects, via the age of weaning (3 months), of maternal pre-pregnancy overweight or obesity on offspring’s BMI and fat mass index. The NDE of maternal overweight or obesity on offspring BMI at 17 years old was 2.63 kg/m2 (95% CI: 2.27 to 2.99). The NIE via the age of weaning was 0.02 kg/m2 (95% CI: 0.00 to 0.04), corresponding to 0.8% of the total effect. Similar results were observed for the offspring’s fat mass index. The NDE and NIE were similar to the main analyses when we looked at the relationship stratified by breastfeeding status. Our study found a minimal influence of age of weaning on the pathway between maternal and offspring adiposity, indicating the age of weaning may not be a key mediator.